These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22148952)

  • 1. Advances in the design and synthesis of prazosin derivatives over the last ten years.
    Desiniotis A; Kyprianou N
    Expert Opin Ther Targets; 2011 Dec; 15(12):1405-18. PubMed ID: 22148952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?
    Tahmatzopoulos A; Kyprianou N
    Prostate; 2004 Apr; 59(1):91-100. PubMed ID: 14991869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.
    Kyprianou N
    J Urol; 2003 Apr; 169(4):1520-5. PubMed ID: 12629407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha1-adrenoceptor antagonists improve bladder storage function through reduction of afferent activity in rats with bladder outlet obstruction.
    Yazaki J; Aikawa K; Shishido K; Yanagida T; Nomiya M; Ishibashi K; Haga N; Yamaguchi O
    Neurourol Urodyn; 2011 Mar; 30(3):461-7. PubMed ID: 20886573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease.
    Kyprianou N; Chon J; Benning CM
    Prostate Suppl; 2000; 9():42-6. PubMed ID: 11056502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.
    Benning CM; Kyprianou N
    Cancer Res; 2002 Jan; 62(2):597-602. PubMed ID: 11809715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
    Kyprianou N; Benning CM
    Cancer Res; 2000 Aug; 60(16):4550-5. PubMed ID: 10969806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
    Keledjian K; Kyprianou N
    J Urol; 2003 Mar; 169(3):1150-6. PubMed ID: 12576871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of relaxation responses of cavernous and trigonal smooth muscles from rabbits by alpha1-adrenoceptor antagonists; prazosin, terazosin, doxazosin, and tamsulosin.
    Seo KK; Lee MY; Lim SW; Kim SC
    J Korean Med Sci; 1999 Feb; 14(1):69-74. PubMed ID: 10102527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drugs for the treatment of benign prostatic hypertrophy].
    Caprino L
    Minerva Urol Nefrol; 2000 Jun; 52(2):87-92. PubMed ID: 11085067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis in the prostate by alpha1-adrenoceptor antagonists: a novel effect of "old" drugs.
    Kyprianou N; Jacobs SC
    Curr Urol Rep; 2000 Aug; 1(2):89-96. PubMed ID: 12084321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic effects and mechanism of prazosin.
    Liao CH; Guh JH; Chueh SC; Yu HJ
    Prostate; 2011 Jun; 71(9):976-84. PubMed ID: 21541974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.
    Williams TJ; Blue DR; Daniels DV; Davis B; Elworthy T; Gever JR; Kava MS; Morgans D; Padilla F; Tassa S; Vimont RL; Chapple CR; Chess-Williams R; Eglen RM; Clarke DE; Ford AP
    Br J Pharmacol; 1999 May; 127(1):252-8. PubMed ID: 10369480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
    Forbes A; Anoopkumar-Dukie S; Chess-Williams R; McDermott C
    Prostate; 2016 Jun; 76(8):757-66. PubMed ID: 26880388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
    Cuellar DC; Rhee J; Kyprianou N
    Anticancer Res; 2002; 22(3):1673-9. PubMed ID: 12168853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
    Na YJ; Guo YL; Gu FL
    J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the Pharmacodynamic Uroselectivity of
    Quaresma BMCS; Pimenta AR; Santos da Silva AC; Pupo AS; Romeiro LAS; Silva CLM; Noël F
    J Pharmacol Exp Ther; 2019 Oct; 371(1):106-112. PubMed ID: 31285236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of terazosin on clinical benign prostatic hyperplasia in older adults.
    Mudiyala R; Ahmed A
    J Am Geriatr Soc; 2003 Mar; 51(3):424-6. PubMed ID: 12588590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo receptor binding of novel alpha1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia.
    Yamada S; Ohkura T; Kimura R; Kawabe K
    Life Sci; 1998; 62(17-18):1585-9. PubMed ID: 9585140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
    Gao X; Abdelkarim H; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
    PLoS One; 2018; 13(9):e0204041. PubMed ID: 30248140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.